Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

USA - NYSE:CBNA - US15746L1008 - Common Stock

29.81 USD
+0.02 (+0.07%)
Last: 10/28/2025, 8:04:00 PM
29.81 USD
0 (0%)
After Hours: 10/28/2025, 8:04:00 PM
Fundamental Rating

4

Overall CBNA gets a fundamental rating of 4 out of 10. We evaluated CBNA against 390 industry peers in the Banks industry. The financial health of CBNA is average, but there are quite some concerns on its profitability. CBNA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CBNA was profitable.
In the past year CBNA had a positive cash flow from operations.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.48%, CBNA belongs to the top of the industry, outperforming 88.97% of the companies in the same industry.
With an excellent Return On Equity value of 13.65%, CBNA belongs to the best of the industry, outperforming 90.51% of the companies in the same industry.
Industry RankSector Rank
ROA 1.48%
ROE 13.65%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

CBNA has a Profit Margin of 37.93%. This is amongst the best in the industry. CBNA outperforms 94.36% of its industry peers.
The Operating Margin and Gross Margin are not available for CBNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 37.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBNA has been increased compared to 1 year ago.
There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC10.05%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

CBNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 132.05%, which is quite impressive.
CBNA shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.68%.
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.88%
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.12%

3.2 Future

The Earnings Per Share is expected to decrease by -1.94% on average over the next years.
The Revenue is expected to grow by 11.86% on average over the next years. This is quite good.
EPS Next Y-27.73%
EPS Next 2Y-1.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.16%
Revenue Next 2Y11.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.89, the valuation of CBNA can be described as very cheap.
CBNA's Price/Earnings ratio is rather cheap when compared to the industry. CBNA is cheaper than 92.31% of the companies in the same industry.
CBNA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.83.
Based on the Price/Forward Earnings ratio of 7.16, the valuation of CBNA can be described as very cheap.
90.00% of the companies in the same industry are more expensive than CBNA, based on the Price/Forward Earnings ratio.
CBNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 7.89
Fwd PE 7.16
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBNA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.96
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.94%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBNA!.
Industry RankSector Rank
Dividend Yield N/A

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (10/28/2025, 8:04:00 PM)

After market: 29.81 0 (0%)

29.81

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)11-04 2025-11-04
Inst Owners47.56%
Inst Owner Change-0.06%
Ins Owners24.89%
Ins Owner Change3.71%
Market Cap195.55M
Revenue(TTM)56.47M
Net Income(TTM)21.42M
Analysts80
Price Target30.6 (2.65%)
Short Float %1.48%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.84%
Min EPS beat(2)30.3%
Max EPS beat(2)53.38%
EPS beat(4)4
Avg EPS beat(4)37.41%
Min EPS beat(4)5.17%
Max EPS beat(4)60.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.99%
Min Revenue beat(2)6.78%
Max Revenue beat(2)25.2%
Revenue beat(4)4
Avg Revenue beat(4)14.55%
Min Revenue beat(4)6.78%
Max Revenue beat(4)25.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)23.86%
EPS NY rev (1m)0%
EPS NY rev (3m)17.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.54%
Valuation
Industry RankSector Rank
PE 7.89
Fwd PE 7.16
P/S 3.46
P/FCF 11.96
P/OCF 10.3
P/B 1.25
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)3.78
EY12.68%
EPS(NY)4.16
Fwd EY13.96%
FCF(TTM)2.49
FCFY8.36%
OCF(TTM)2.89
OCFY9.71%
SpS8.61
BVpS23.93
TBVpS23.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number45.11
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 13.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 37.93%
GM N/A
FCFM 28.95%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 547.4%
Cap/Sales 4.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 76.34%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.88%
EPS Next Y-27.73%
EPS Next 2Y-1.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.12%
Revenue Next Year6.16%
Revenue Next 2Y11.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A

CHAIN BRIDGE BANCORP INC-A / CBNA FAQ

Can you provide the ChartMill fundamental rating for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to CBNA.


Can you provide the valuation status for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a valuation rating of 5 / 10 to CHAIN BRIDGE BANCORP INC-A (CBNA). This can be considered as Fairly Valued.


How profitable is CHAIN BRIDGE BANCORP INC-A (CBNA) stock?

CHAIN BRIDGE BANCORP INC-A (CBNA) has a profitability rating of 3 / 10.


Can you provide the financial health for CBNA stock?

The financial health rating of CHAIN BRIDGE BANCORP INC-A (CBNA) is 4 / 10.


Can you provide the expected EPS growth for CBNA stock?

The Earnings per Share (EPS) of CHAIN BRIDGE BANCORP INC-A (CBNA) is expected to decline by -27.73% in the next year.